Richard Pulik - 20 Oct 2021 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Issuer symbol
ROIV
Transactions as of
20 Oct 2021
Transactions value $
$0
Form type
4
Filing time
22 Oct 2021, 16:07:18 UTC
Previous filing
01 Oct 2021
Next filing
22 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +313,419 $0.000000 313,419 20 Oct 2021 Common Shares 313,419 $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options ("Options") to purchase Common Shares with a vesting commencement date of September 28, 2021. Award of Options vests and becomes exercisable as follows: (i) 25% on the one-year anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.